003:ACUTE_LYMPHOBLASTIC_LEUKAEMIA	MMI	17.80	Precursor Cell Lymphoblastic Leukemia Lymphoma	C1961102	[neop]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKAEMIA"-noun-0]	TX	0/29	C04.557.337.428.600;C15.604.515.560.600;C20.683.515.528.600
004:ACUTE_LYMPHOBLASTIC_LEUKAEMIA	MMI	5.18	Acute lymphocytic leukemia	C0023449	[neop]	["Acute lymphoblastic leukaemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKAEMIA"-noun-0]	TX	0/29	
005:ACUTE_LYMPHOBLASTIC_LEUKEMIA	MMI	17.80	Precursor Cell Lymphoblastic Leukemia Lymphoma	C1961102	[neop]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.428.600;C15.604.515.560.600;C20.683.515.528.600
006:ACUTE_LYMPHOBLASTIC_LEUKEMIA	MMI	5.18	Acute lymphocytic leukemia	C0023449	[neop]	["Acute lymphoblastic leukaemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKEMIA"-noun-0]	TX	0/28	
007:ACUTE_MONOCYTIC_LEUKEMIA	MMI	20.95	Acute monocytic leukemia	C0023465	[neop]	["Acute monocytic leukaemia"-tx-1-"ACUTE MONOCYTIC LEUKEMIA"-noun-0]	TX	0/24	C04.557.337.539.275.484
008:ACUTE_MONOCYTIC_LEUKEMIA	MMI	5.18	M5b Acute differentiated monocytic leukemia	C1318544	[neop]	["Acute Monocytic Leukemia"-tx-1-"ACUTE MONOCYTIC LEUKEMIA"-noun-0]	TX	0/24	
011:ACUTE_MYELOID_LEUKEMIA_(AML)	AA	AML	ACUTE MYELOID LEUKEMIA	1	3	5	22	24:3
012:ACUTE_MYELOID_LEUKEMIA_(AML)	MMI	17.80	Leukemia, Myelocytic, Acute	C0023467	[neop]	["Acute myeloid leukaemia"-tx-1-"ACUTE MYELOID LEUKEMIA"-noun-0]	TX	0/22	C04.557.337.539.275
016:ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	16.40	Appendicitis	C0003615	[dsyn]	["Acute Appendicitis"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	C01.539.463.099;C06.405.205.099;C06.405.469.110.207
017:ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	3.78	Acute appendicitis NOS (disorder)	C0085693	[dsyn]	["APPENDICITIS, ACUTE"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	
019:ACUTE_SIMPLE_APPENDICITIS	MMI	16.40	Appendicitis	C0003615	[dsyn]	["Acute Appendicitis"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,13/12	C01.539.463.099;C06.405.205.099;C06.405.469.110.207
020:ACUTE_SIMPLE_APPENDICITIS	MMI	3.78	Acute appendicitis NOS (disorder)	C0085693	[dsyn]	["APPENDICITIS, ACUTE"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,13/12	
026:ALZHEIMER'S_DISEASE	MMI	16.40	Alzheimer's Disease	C0002395	[dsyn]	["ALZHEIMER DISEASE"-tx-1-"ALZHEIMER DISEASE"-noun-0]	TX	0/9,12/7	C10.228.140.380.100;C10.574.945.249;F03.615.400.100
027:ALZHEIMER'S_DISEASE	MMI	3.78	Alzheimer's Disease Pathway KEGG	C1521724	[patf]	["Alzheimer's Disease"-tx-1-"ALZHEIMER DISEASE"-noun-0]	TX	0/9,12/7	
029:AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	16.21	Leukemia, Myelocytic, Acute	C0023467	[neop]	["AML"-tx-1-"AML"-noun-0]	TX	0/3	C04.557.337.539.275
030:AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	16.07	Chromosome inversion	C0021943	[comd]	["inv"-tx-1-"INV"-adj-0]	TX	9/3	C23.550.210.190;G05.355.600.805.500;G05.365.590.175.190;G05.365.590.770.500
031:AML_WITH_MDS-RELATED_CHANGES	MMI	3.67	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	[neop]	["AML/MDS"-tx-1-"AML MDS"-noun-0]	TX	0/3,9/3	
032:AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Related personal status	C0445223	[fndg]	["Related"-tx-1-"RELATED"-adj-0]	TX	13/7	
034:ANAPLASTIC_THYROID_CANCER	MMI	17.80	Anaplastic thyroid carcinoma	C0238461	[neop]	["Anaplastic Thyroid Cancer"-tx-1-"ANAPLASTIC THYROID CANCER"-noun-0]	TX	0/25	C04.557.470.200.725
034:ANAPLASTIC_THYROID_CANCER	MMI	17.80	Anaplastic thyroid carcinoma	C0238461	[neop]	["Anaplastic Thyroid Cancer"-tx-1-"ANAPLASTIC THYROID CANCER"-noun-0]	TX	0/25	C04.557.470.200.725
040:ATOPIC_DERMATITIS_(AD)	AA	AD	ATOPIC DERMATITIS	1	2	3	17	19:2
041:ATOPIC_DERMATITIS_(AD)	MMI	14.64	Dermatitis, Atopic	C0011615	[dsyn]	["ATOPIC DERMATITIS"-tx-1-"ATOPIC DERMATITIS"-noun-0]	TX	0/17	C16.320.850.210;C17.800.174.193;C17.800.815.193;C17.800.827.210;C20.543.480.343
042:ATOPIC_DERMATITIS_(AD)	MMI	14.64	Eczema	C0013595	[dsyn]	["Atopic Dermatitis"-tx-1-"ATOPIC DERMATITIS"-noun-0]	TX	0/17	C17.800.174.620;C17.800.815.620
043:AUTOIMMUNE_HEPATITIS	MMI	17.80	Hepatitis, Autoimmune	C0241910	[dsyn]	["Autoimmune Hepatitis"-tx-1-"AUTOIMMUNE HEPATITIS"-noun-0]	TX	0/20	C06.552.380.350.050;C20.111.567
044:AUTOINFLAMMATORY_SYNDROME_WITH_IMMUNE_DEFICIENCY	MMI	6.64	Immunologic Deficiency Syndromes	C0021051	[dsyn]	["Immune deficiency"-tx-1-"IMMUNE DEFICIENCY"-noun-0]	TX	31/17	C20.673
045:AUTOINFLAMMATORY_SYNDROME_WITH_IMMUNE_DEFICIENCY	MMI	3.65	Autoinflammatory Syndrome	C3890737	[dsyn]	["Autoinflammatory Syndrome"-tx-1-"AUTOINFLAMMATORY SYNDROME"-noun-0]	TX	0/25	
046:B-ALL	MMI	24.11	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
047:B-ALL	MMI	5.18	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
048:B-ALL_NOS	MMI	24.11	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
048:B-ALL_NOS	MMI	24.11	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
049:B-ALL_NOS	MMI	5.18	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
049:B-ALL_NOS	MMI	5.18	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
050:B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	22.53	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
050:B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	22.53	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
051:B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	3.60	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
051:B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	3.60	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
052:B-ALL_WITH_T(9;22)_BCR-ABL	MMI	22.54	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
052:B-ALL_WITH_T(9;22)_BCR-ABL	MMI	22.54	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
053:B-ALL_WITH_T(9;22)_BCR-ABL	MMI	3.61	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
053:B-ALL_WITH_T(9;22)_BCR-ABL	MMI	3.61	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
054:B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	22.37	Burkitt Lymphoma	C0006413	[neop]	["BL"-tx-1-"BL"-noun-0]	TX	78/2	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
055:B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	22.37	Diffuse Large B-Cell Lymphoma	C0079744	[neop]	["DLBCL"-tx-1-"DLBCL"-noun-0]	TX	68/5	C04.557.386.480.150.585;C15.604.515.569.480.150.585;C20.683.515.761.480.150.585
056:B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	19.39	B-Cell Lymphomas	C0079731	[neop]	["B cell lymphoma"-tx-1-"B-CELL LYMPHOMA"-noun-0]	TX	0/15	C04.557.386.480.150;C15.604.515.569.480.150;C20.683.515.761.480.150
057:BECKER'S_NEVUS	MMI	3.78	Pigmented hairy epidermal nevus	C0263579	[neop]	["Becker's naevus"-tx-1-"BECKER NEVUS"-noun-0]	TX	0/6,9/5	
058:BECKERS_NEVUS_SYNDROME	MMI	13.65	Becker Nevus Syndrome	C1858042	[dsyn]	["BECKER NEVUS SYNDROME"-tx-1-"BECKERS NEVUS SYNDROME"-noun-0]	TX	0/22	x.x.x.x
060:BLADDER_CANCER	MMI	5.18	Carcinoma of bladder	C0699885	[neop]	["Bladder Cancer"-tx-1-"BLADDER CANCER"-noun-0]	TX	0/14	
060:BLADDER_CANCER	MMI	5.18	Carcinoma of bladder	C0699885	[neop]	["Bladder Cancer"-tx-1-"BLADDER CANCER"-noun-0]	TX	0/14	
061:BLADDER_CANCER	MMI	5.18	Malignant neoplasm of urinary bladder	C0005684	[neop]	["BLADDER CANCER"-tx-1-"BLADDER CANCER"-noun-0]	TX	0/14	
061:BLADDER_CANCER	MMI	5.18	Malignant neoplasm of urinary bladder	C0005684	[neop]	["BLADDER CANCER"-tx-1-"BLADDER CANCER"-noun-0]	TX	0/14	
064:BLUNT_FORCE_TRAUMA_(BFT)	AA	BFT	BLUNT FORCE TRAUMA	1	3	5	18	20:3
065:BLUNT_FORCE_TRAUMA_(BFT)	MMI	8.34	Nonpenetrating Wounds	C0043253	[inpo]	["Blunt force Trauma"-tx-1-"BLUNT FORCE TRAUMA"-noun-0]	TX	0/18	C26.974
066:BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.76	Encounter for being a bone marrow donor	C1313934	[fndg]	["Bone marrow donors"-tx-1-"BONE MARROW DONORS"-noun-0]	TX	0/11,31/6	
067:BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Encounter due to being a donor	C1527169	[fndg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
071:BREAST_CANCER	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	C04.588.180;C17.800.090.500
071:BREAST_CANCER	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	C04.588.180;C17.800.090.500
072:BREAST_CANCER	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	
072:BREAST_CANCER	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	
073:BREAST_CARCINOMA	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["BREAST CARCINOMA"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	C04.588.180;C17.800.090.500
074:BREAST_CARCINOMA	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["Breast Carcinoma"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	
075:BREAST_DUCTAL_CARCINOMA	MMI	24.11	Mammary Ductal Carcinoma	C0021367	[neop]	["breast ductal carcinoma"-tx-1-"BREAST DUCTAL CARCINOMA"-noun-0]	TX	0/23	C04.557.470.200.025.232.500;C04.557.470.615.132.500;C04.588.180.390;C17.800.090.500.390
079:CANCER	MMI	5.18	Malignant Neoplasms	C0006826	[neop]	["CANCER"-tx-1-"CANCER"-noun-0]	TX	0/6	
080:CANCER	MMI	5.18	Primary malignant neoplasm	C1306459	[neop]	["Cancer"-tx-1-"CANCER"-noun-0]	TX	0/6	
081:CANCER_PAIN	MMI	5.18	cancer pain	C0596240	[sosy]	["cancer pain"-tx-1-"CANCER PAIN"-noun-0]	TX	0/11	
087:CERVICAL_CANCER	MMI	5.18	Cervix carcinoma	C0302592	[neop]	["CERVICAL CANCER"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
087:CERVICAL_CANCER	MMI	5.18	Cervix carcinoma	C0302592	[neop]	["CERVICAL CANCER"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
088:CERVICAL_CANCER	MMI	5.18	Malignant tumor of cervix	C0007847	[neop]	["Cervical cancer"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
088:CERVICAL_CANCER	MMI	5.18	Malignant tumor of cervix	C0007847	[neop]	["Cervical cancer"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
089:CERVICAL_CANCER	MMI	5.18	cervical cancer	C4048328	[neop]	["CERVICAL CANCER"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
089:CERVICAL_CANCER	MMI	5.18	cervical cancer	C4048328	[neop]	["CERVICAL CANCER"-tx-1-"CERVICAL CANCER"-noun-0]	TX	0/15	
092:CHRONIC_LYMPHOCYTIC_LEUKEMIA_(CLL)	AA	CLL	CHRONIC LYMPHOCYTIC LEUKEMIA	1	3	5	28	30:3
093:CHRONIC_LYMPHOCYTIC_LEUKEMIA_(CLL)	MMI	20.95	Chronic Lymphocytic Leukemia	C0023434	[neop]	["Chronic lymphocytic leukaemia"-tx-1-"CHRONIC LYMPHOCYTIC LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.428.080.125;C15.604.515.560.080.125;C20.683.515.528.080.125
097:CHRONIC_PANCREATITIS	MMI	14.64	Hereditary pancreatitis	C0238339	[dsyn]	["PANCREATITIS, CHRONIC"-tx-1-"CHRONIC PANCREATITIS"-noun-0]	TX	0/20	x.x.x.x
098:CHRONIC_PANCREATITIS	MMI	14.64	Pancreatitis, Chronic	C0149521	[dsyn]	["Chronic Pancreatitis"-tx-1-"CHRONIC PANCREATITIS"-noun-0]	TX	0/20	C06.689.750.830
099:CIRRHOSIS	MMI	11.49	Cirrhosis	C1623038	[dsyn]	["Cirrhosis"-tx-1-"CIRRHOSIS"-noun-0]	TX	0/9	C23.550.355
100:CIRRHOSIS	MMI	11.49	Liver Cirrhosis	C0023890	[dsyn]	["CIRRHOSIS"-tx-1-"CIRRHOSIS"-noun-0]	TX	0/9	C06.552.630
102:COLON_CANCER	MMI	5.18	Colon Carcinoma	C0699790	[neop]	["COLON CANCER"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
102:COLON_CANCER	MMI	5.18	Colon Carcinoma	C0699790	[neop]	["COLON CANCER"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
103:COLON_CANCER	MMI	5.18	Malignant tumor of colon	C0007102	[neop]	["-- Colon Cancer"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
103:COLON_CANCER	MMI	5.18	Malignant tumor of colon	C0007102	[neop]	["-- Colon Cancer"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
105:COLON_CARCINOMA,_PRIMARY	MMI	3.78	Primary Carcinoma	C1335475	[neop]	["Primary Carcinoma"-tx-1-"CARCINOMA PRIMARY"-noun-0]	TX	6/9,17/7	
106:COLON_CARCINOMA,_PRIMARY	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
107:COLON_CARCINOMA,_SPORADIC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
108:COLON_CARCINOMA,_SPORADIC	MMI	3.48	Isolated cases	C1853237	[fndg]	["Sporadic"-tx-1-"SPORADIC"-adj-0]	TX	17/8	
111:COLORECTAL_CANCER	MMI	20.95	Colorectal Cancer	C1527249	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
111:COLORECTAL_CANCER	MMI	20.95	Colorectal Cancer	C1527249	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
112:COLORECTAL_CANCER	MMI	20.95	Colorectal Carcinoma	C0009402	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
112:COLORECTAL_CANCER	MMI	20.95	Colorectal Carcinoma	C0009402	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
123:DIFFUSE_LARGE_B-CELL_LYMPHOMA	MMI	24.11	Diffuse Large B-Cell Lymphoma	C0079744	[neop]	["Diffuse Large B-Cell Lymphoma"-tx-1-"DIFFUSE LARGE B-CELL LYMPHOMA"-noun-0]	TX	0/29	C04.557.386.480.150.585;C15.604.515.569.480.150.585;C20.683.515.761.480.150.585
124:DIFFUSE_LARGE_B-CELL_LYMPHOMA	MMI	5.18	Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	C2699777	[neop]	["Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"-tx-1-"DIFFUSE LARGE B-CELL LYMPHOMA"-noun-0]	TX	0/29	
129:DUCTAL_CARCINOMA	MMI	20.95	Ductal Carcinoma	C1176475	[neop]	["Ductal Carcinoma"-tx-1-"DUCTAL CARCINOMA"-noun-0]	TX	0/16	C04.557.470.200.025.232;C04.557.470.615.132
130:DUCTAL_CARCINOMA	MMI	5.18	Ductal Breast Carcinoma	C1527349	[neop]	["Ductal Carcinoma"-tx-1-"DUCTAL CARCINOMA"-noun-0]	TX	0/16	
133:ENDOMETRIAL_CANCER	MMI	20.95	Endometrial Carcinoma	C0476089	[neop]	["ENDOMETRIAL CANCER"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	C04.588.945.418.948.585;C13.351.500.852.762.200;C13.351.937.418.875.200
133:ENDOMETRIAL_CANCER	MMI	20.95	Endometrial Carcinoma	C0476089	[neop]	["ENDOMETRIAL CANCER"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	C04.588.945.418.948.585;C13.351.500.852.762.200;C13.351.937.418.875.200
134:ENDOMETRIAL_CANCER	MMI	5.18	Malignant neoplasm of endometrium	C0007103	[neop]	["Endometrial cancer"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	
134:ENDOMETRIAL_CANCER	MMI	5.18	Malignant neoplasm of endometrium	C0007103	[neop]	["Endometrial cancer"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	
135:ENDOMETRIAL_CANCER	MMI	5.18	Uterine Corpus Cancer	C1883486	[neop]	["Endometrial Cancer"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	
135:ENDOMETRIAL_CANCER	MMI	5.18	Uterine Corpus Cancer	C1883486	[neop]	["Endometrial Cancer"-tx-1-"ENDOMETRIAL CANCER"-noun-0]	TX	0/18	
137:ENDOMETRIOID_ENDOMETRIAL_CANCER	MMI	5.18	Endometrial Endometrioid Adenocarcinoma	C1336905	[neop]	["Endometrioid Endometrial Cancer"-tx-1-"ENDOMETRIOID ENDOMETRIAL CANCER"-noun-0]	TX	0/31	
137:ENDOMETRIOID_ENDOMETRIAL_CANCER	MMI	5.18	Endometrial Endometrioid Adenocarcinoma	C1336905	[neop]	["Endometrioid Endometrial Cancer"-tx-1-"ENDOMETRIOID ENDOMETRIAL CANCER"-noun-0]	TX	0/31	
138:ENTERIC_VOLVULUS,_HEMORRHAGIC_INFARCT	MMI	16.23	Intestinal Volvulus	C0042961	[dsyn]	["Volvulus"-tx-1-"VOLVULUS"-noun-0]	TX	8/8	C06.405.469.531.568;C23.300.970.500
139:ENTERIC_VOLVULUS,_HEMORRHAGIC_INFARCT	MMI	3.50	Hemorrhagic infarct	C0333549	[patf]	["Hemorrhagic infarct"-tx-1-"HEMORRHAGIC INFARCT"-noun-0]	TX	18/19	
140:EOSINOPHILIA	MMI	14.64	Eosinophilia	C0014457	[dsyn]	["EOSINOPHILIA"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	C15.378.553.231
141:EOSINOPHILIA	MMI	5.18	Eosinophilic disorder	C1306759	[dsyn]	["Eosinophilia"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	
145:ESOPAGEAL_CANCER	MMI	3.68	Malignant Neoplasms	C0006826	[neop]	["CANCER"-tx-1-"CANCER"-noun-0]	TX	10/6	
145:ESOPAGEAL_CANCER	MMI	3.68	Malignant Neoplasms	C0006826	[neop]	["CANCER"-tx-1-"CANCER"-noun-0]	TX	10/6	
146:ESOPAGEAL_CANCER	MMI	3.68	Primary malignant neoplasm	C1306459	[neop]	["Cancer"-tx-1-"CANCER"-noun-0]	TX	10/6	
146:ESOPAGEAL_CANCER	MMI	3.68	Primary malignant neoplasm	C1306459	[neop]	["Cancer"-tx-1-"CANCER"-noun-0]	TX	10/6	
148:ESOPHAGEAL_CANCER	MMI	17.80	Esophageal Neoplasms	C0014859	[neop]	["esophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.205;C04.588.443.353;C06.301.371.205;C06.405.117.430;C06.405.249.205
148:ESOPHAGEAL_CANCER	MMI	17.80	Esophageal Neoplasms	C0014859	[neop]	["esophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.205;C04.588.443.353;C06.301.371.205;C06.405.117.430;C06.405.249.205
149:ESOPHAGEAL_CANCER	MMI	5.18	Esophageal carcinoma	C0152018	[neop]	["ESOPHAGEAL CANCER"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
149:ESOPHAGEAL_CANCER	MMI	5.18	Esophageal carcinoma	C0152018	[neop]	["ESOPHAGEAL CANCER"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
150:ESOPHAGEAL_CANCER	MMI	5.18	Malignant neoplasm of esophagus	C0546837	[neop]	["Oesophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
150:ESOPHAGEAL_CANCER	MMI	5.18	Malignant neoplasm of esophagus	C0546837	[neop]	["Oesophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
153:EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Marginal Zone B-Cell Lymphoma	C1367654	[neop]	["Marginal Zone Lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
153:EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Marginal Zone B-Cell Lymphoma	C1367654	[neop]	["Marginal Zone Lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
154:EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["marginal zone lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
154:EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["marginal zone lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
155:FIBROSIS_(NON-SARCOIDOSIS)	MMI	12.94	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-adj-1]	TX	14/11	C15.604.515.827
156:FIBROSIS_(NON-SARCOIDOSIS)	MMI	9.94	Fibrosis	C0016059	[patf]	["FIBROSIS"-tx-1-"FIBROSIS"-noun-1]	TX	0/8	C23.550.355
157:FIBROSIS_(NON-SARCOIDOSIS)	MMI	3.48	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-adj-1]	TX	14/11	
158:FLT3-ITD_MUTANT_ACUTE_MYELOID_LEUKEMIA	MMI	16.30	Leukemia, Myelocytic, Acute	C0023467	[neop]	["Acute myeloid leukaemia"-tx-1-"ACUTE MYELOID LEUKEMIA"-noun-0]	TX	16/22	C04.557.337.539.275
159:FLT3-ITD_MUTANT_ACUTE_MYELOID_LEUKEMIA	MMI	3.46	mutant	C0596988	[comd]	["Mutant"-tx-1-"MUTANT"-adj-0]	TX	9/6	
164:GASTRIC_CANCER	MMI	5.18	Malignant neoplasm of stomach	C0024623	[neop]	["-- Gastric Cancer"-tx-1-"GASTRIC_CANCER"-noun-0]	TX	0/14	
164:GASTRIC_CANCER	MMI	5.18	Malignant neoplasm of stomach	C0024623	[neop]	["-- Gastric Cancer"-tx-1-"GASTRIC_CANCER"-noun-0]	TX	0/14	
165:GASTRIC_CANCER	MMI	5.18	Stomach Carcinoma	C0699791	[neop]	["GASTRIC CANCER"-tx-1-"GASTRIC_CANCER"-noun-0]	TX	0/14	
165:GASTRIC_CANCER	MMI	5.18	Stomach Carcinoma	C0699791	[neop]	["GASTRIC CANCER"-tx-1-"GASTRIC_CANCER"-noun-0]	TX	0/14	
168:GIST	MMI	17.80	Gastrointestinal Stromal Tumors	C0238198	[neop]	["GIST"-tx-1-"GIST"-noun-0]	TX	0/4	C04.557.450.565.370;C06.301.371.308;C06.405.249.308
169:GIST	MMI	14.64	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	C1847319	[neop]	["GIST"-tx-1-"GIST"-noun-0]	TX	0/4	x.x.x.x
170:GLIOBLASTOMA;_ASTROCYTOMA	MMI	25.76	Glioblastoma	C0017636	[neop]	["Glioblastoma"-tx-1-"GLIOBLASTOMA"-noun-0]	TX	0/12	C04.557.465.625.600.380.080.335;C04.557.470.670.380.080.335;C04.557.580.625.600.380.080.335
171:GLIOBLASTOMA;_ASTROCYTOMA	MMI	22.43	Astrocytoma	C0004114	[neop]	["ASTROCYTOMA"-tx-1-"ASTROCYTOMA"-noun-0]	TX	14/11	C04.557.465.625.600.380.080;C04.557.470.670.380.080;C04.557.580.625.600.380.080
173:GLIOBLASTOMA_MULTIFORME	MMI	27.26	Glioblastoma	C0017636	[neop]	["Glioblastoma multiforme"-tx-1-"GLIOBLASTOMA MULTIFORME"-noun-0]	TX	0/23	C04.557.465.625.600.380.080.335;C04.557.470.670.380.080.335;C04.557.580.625.600.380.080.335
174:GLIOBLASTOMA_MULTIFORME	MMI	27.26	Glioblastoma Multiforme	C1621958	[neop]	["GLIOBLASTOMA MULTIFORME"-tx-1-"GLIOBLASTOMA MULTIFORME"-noun-0]	TX	0/23	C04.557.465.625.600.380.080.335;C04.557.470.670.380.080.335;C04.557.580.625.600.380.080.335
177:HCV_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	4/9	C01.539.221
178:HCV_INFECTION	MMI	6.83	Infection	C3714514	[patf]	["INFECTION"-tx-1-"INFECTION"-noun-0]	TX	4/9	C01.539
183:HEPATITIS	MMI	17.80	Hepatitis A	C0019159	[dsyn]	["Hepatitis"-tx-1-"HEPATITIS"-noun-0]	TX	0/9	C02.440.420;C02.782.687.359.500;C06.552.380.705.422
184:HEPATITIS	MMI	11.49	Hepatitis	C0019158	[dsyn]	["HEPATITIS"-tx-1-"HEPATITIS"-noun-0]	TX	0/9	C06.552.380
186:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	AA	HGSOC	HIGH-GRADE SEROUS OVARIAN CANCER	1	5	9	32	34:5
186:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	AA	HGSOC	HIGH-GRADE SEROUS OVARIAN CANCER	1	5	9	32	34:5
186:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	AA	HGSOC	HIGH-GRADE SEROUS OVARIAN CANCER	1	5	9	32	34:5
187:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	MMI	3.72	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Serous ovarian cancer"-tx-1-"SEROUS OVARIAN CANCER"-noun-0]	TX	11/21	
187:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	MMI	3.72	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Serous ovarian cancer"-tx-1-"SEROUS OVARIAN CANCER"-noun-0]	TX	11/21	
187:HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	MMI	3.72	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Serous ovarian cancer"-tx-1-"SEROUS OVARIAN CANCER"-noun-0]	TX	11/21	
190:HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	16.45	HIV Infections	C0019693	[dsyn]	["Human immunodeficiency virus disease"-tx-1-"HUMAN IMMUNODEFICIENCY VIRUS DISEASE"-noun-0]	TX	0/28,40/7	C02.782.815.616.400;C02.800.801.400;C20.673.480
191:HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	9.84	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539.221
192:HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	6.69	Infection	C3714514	[patf]	["Infections"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539
196:HYPERLIPIDEMIA	MMI	17.80	Hyperlipidemia	C0020473	[dsyn]	["Hyperlipidaemia, NOS"-tx-1-"HYPERLIPIDEMIA"-noun-0]	TX	0/14	C18.452.584.500.500
197:HYPERLIPIDEMIA	MMI	5.18	Serum lipids high (finding)	C0428465	[fndg]	["Hyperlipidemia"-tx-1-"HYPERLIPIDEMIA"-noun-0]	TX	0/14	
199:HYPER_IGD_SYNDROME_(HIDS)	AA	HIDS	HYPER IGD SYNDROME	1	4	5	18	20:4
200:HYPER_IGD_SYNDROME_(HIDS)	MMI	20.95	Hyperimmunoglobulinemia D	C0398691	[dsyn]	["HYPER-IgD SYNDROME"-tx-1-"HYPER IGD SYNDROME"-noun-0]	TX	0/18	C10.228.140.163.100.593;C15.378.147.542.319;C16.320.382.750;C16.320.565.189.593;C16.320.565.663.430;C18.452.132.100.593;C18.452.648.189.593;C18.452.648.663.430;C20.683.460.319
204:ICHTHYOSIS_VULGARIS_(IV)	AA	IV	ICHTHYOSIS VULGARIS	1	2	3	19	21:2
205:ICHTHYOSIS_VULGARIS_(IV)	MMI	17.80	Ichthyosis Vulgaris	C0079584	[cgab,dsyn]	["ICHTHYOSIS VULGARIS"-tx-1-"ICHTHYOSIS VULGARIS"-noun-0]	TX	0/19	C16.131.831.512.410;C16.320.850.405;C17.800.428.333.410;C17.800.804.512.410;C17.800.827.405
210:LARGE_CELL_LUNG_CANCER	MMI	5.18	Large cell carcinoma of lung	C0345958	[neop]	["large cell lung cancer"-tx-1-"LARGE CELL LUNG CANCER"-noun-0]	TX	0/22	
210:LARGE_CELL_LUNG_CANCER	MMI	5.18	Large cell carcinoma of lung	C0345958	[neop]	["large cell lung cancer"-tx-1-"LARGE CELL LUNG CANCER"-noun-0]	TX	0/22	
212:LISSENCEPHALY(XLAG)	MMI	19.45	Lissencephaly	C0266463	[cgab]	["Lissencephaly"-tx-1-"LISSENCEPHALY"-noun-0]	TX	0/13	C10.500.507.450.499;C16.131.666.507.450.499
213:LISSENCEPHALY(XLAG)	MMI	12.96	Lissencephaly, X-Linked, 2	C1846171	[dsyn]	["XLAG"-tx-1-"XLAG"-noun-0]	TX	14/4	x.x.x.x
214:LISSENCEPHALY(XLAG)	MMI	3.50	CHROMOSOME Xq26.3 DUPLICATION SYNDROME	C3891556	[dsyn]	["XLAG"-tx-1-"XLAG"-noun-0]	TX	14/4	
216:LIVER_CANCER	MMI	5.18	Liver and Intrahepatic Biliary Tract Carcinoma	C0279000	[neop]	["Liver Cancer"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
216:LIVER_CANCER	MMI	5.18	Liver and Intrahepatic Biliary Tract Carcinoma	C0279000	[neop]	["Liver Cancer"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
217:LIVER_CANCER	MMI	5.18	Malignant neoplasm of liver	C0345904	[neop]	["Cancer, Liver"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
217:LIVER_CANCER	MMI	5.18	Malignant neoplasm of liver	C0345904	[neop]	["Cancer, Liver"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
218:LOFGREN'S_SYNDROME_(LS)_SARCOIDOSIS	AA	LS	LOFGREN'S SYNDROME	1	2	5	18	20:2
219:LOFGREN'S_SYNDROME_(LS)_SARCOIDOSIS	MMI	13.08	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-0]	TX	24/11	C15.604.515.827
220:LOFGREN'S_SYNDROME_(LS)_SARCOIDOSIS	MMI	3.61	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-0]	TX	24/11	
221:LOFGREN'S_SYNDROME_(LS)_SARCOIDOSIS	MMI	3.51	Lofgrens syndrome	C0340164	[dsyn]	["Lofgren's syndrome"-tx-1-"LOFGREN SYNDROME"-noun-0]	TX	0/7,10/8	
222:LOFGREN'S_SYNDROME_SARCOIDOSIS	MMI	13.08	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-0]	TX	19/11	C15.604.515.827
223:LOFGREN'S_SYNDROME_SARCOIDOSIS	MMI	3.61	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-0]	TX	19/11	
224:LOFGREN'S_SYNDROME_SARCOIDOSIS	MMI	3.51	Lofgrens syndrome	C0340164	[dsyn]	["Lofgren's syndrome"-tx-1-"LOFGREN SYNDROME"-noun-0]	TX	0/7,10/8	
227:LUMINAL_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	C04.588.180;C17.800.090.500
227:LUMINAL_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	C04.588.180;C17.800.090.500
227:LUMINAL_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	C04.588.180;C17.800.090.500
228:LUMINAL_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	
228:LUMINAL_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	
228:LUMINAL_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	
230:LUNG_CANCER	MMI	5.18	Carcinoma of lung	C0684249	[neop]	["-- Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
230:LUNG_CANCER	MMI	5.18	Carcinoma of lung	C0684249	[neop]	["-- Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
231:LUNG_CANCER	MMI	5.18	Malignant neoplasm of lung	C0242379	[neop]	["Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
231:LUNG_CANCER	MMI	5.18	Malignant neoplasm of lung	C0242379	[neop]	["Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
232:LUNG_CANCER	MMI	5.18	Primary malignant neoplasm of lung	C1306460	[neop]	["Lung cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
232:LUNG_CANCER	MMI	5.18	Primary malignant neoplasm of lung	C1306460	[neop]	["Lung cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
238:MALIGNANT_MELANOMA	MMI	20.95	melanoma	C0025202	[neop]	["MALIGNANT MELANOMA"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	C04.557.465.625.650.510;C04.557.580.625.650.510;C04.557.665.510
239:MALIGNANT_MELANOMA	MMI	14.64	Cutaneous Melanoma	C0151779	[neop]	["MELANOMA, MALIGNANT"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	x.x.x.x
243:MESOTHELIOMA	MMI	17.80	Mesothelioma	C0025500	[neop]	["MESOTHELIOMA"-tx-1-"MESOTHELIOMA"-noun-0]	TX	0/12	C04.557.470.035.510;C04.557.470.660.510
244:MESOTHELIOMA	MMI	5.18	Mesothelioma (malignant, clinical disorder) (disorder)	C1290375	[neop]	["Mesothelioma"-tx-1-"MESOTHELIOMA"-noun-0]	TX	0/12	
257:NEUROBLASTOMA	MMI	27.26	Neuroblastoma	C0027819	[neop]	["NEUROBLASTOMA"-tx-1-"NEUROBLASTOMA"-noun-0]	TX	0/13	C04.557.465.625.600.590.650.550;C04.557.470.670.590.650.550;C04.557.580.625.600.590.650.550
258:NEUROBLASTOMA	MMI	5.18	Central neuroblastoma	C0700095	[neop]	["neuroblastoma"-tx-1-"NEUROBLASTOMA"-noun-0]	TX	0/13	
259:NEVUS	MMI	17.80	Melanocytic nevus	C0027962	[neop]	["Nevus"-tx-1-"NEVUS"-noun-0]	TX	0/5	C04.557.665.560.615
260:NEVUS	MMI	14.64	Nevus	C0027960	[neop]	["NEVUS"-tx-1-"NEVUS"-noun-0]	TX	0/5	C04.557.665.560
261:NEVUS	MMI	5.18	Benign melanocytic nevus	C1456781	[neop]	["nevus"-tx-1-"NEVUS"-noun-0]	TX	0/5	
262:NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	24.11	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["Nodal marginal zone lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
263:NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Monocytoid B-cell lymphoma	C0855139	[neop]	["Nodal Marginal Zone Lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	
264:NON-LS_SARCOIDOSIS	MMI	13.09	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-1]	TX	7/11	C15.604.515.827
265:NON-LS_SARCOIDOSIS	MMI	3.63	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-1]	TX	7/11	
267:NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	16.25	Atherosclerosis	C0004153	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126.307
268:NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	13.09	Arteriosclerosis	C0003850	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126
269:NON-SMALL_CELL_LUNG_CANCER	MMI	27.26	Non-Small Cell Lung Carcinoma	C0007131	[neop]	["Lung cancer, non-small cell"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	C04.588.894.797.520.109.220.249;C08.381.540.140.500;C08.785.520.100.220.500
269:NON-SMALL_CELL_LUNG_CANCER	MMI	27.26	Non-Small Cell Lung Carcinoma	C0007131	[neop]	["Lung cancer, non-small cell"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	C04.588.894.797.520.109.220.249;C08.381.540.140.500;C08.785.520.100.220.500
270:NORMAL_BENIGN_SKIN_LESION	MMI	3.70	Skin appearance normal (finding)	C0558145	[fndg]	["Normal Skin"-tx-1-"NORMAL SKIN"-noun-0]	TX	0/6,14/4	
271:NORMAL_BENIGN_SKIN_LESION	MMI	3.68	Skin lesion	C0037284	[dsyn]	["SKIN LESION"-tx-1-"SKIN LESION"-noun-0]	TX	14/11	
272:NORMAL_BENIGN_SKIN_LESION	MMI	3.61	Lesion	C0221198	[fndg]	["Lesion"-tx-1-"LESION"-noun-0]	TX	19/6	
273:NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Gait normal	C0231683	[fndg]	["Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
275:NORMAL_NON_SMOKERS	MMI	3.75	Non-smoker	C0337672	[fndg]	["non smokers"-tx-1-"NON SMOKERS"-noun-0]	TX	7/11	
276:NORMAL_NON_SMOKERS	MMI	3.48	Gait normal	C0231683	[fndg]	["Normal"-tx-1-"NORMAL"-adj-1]	TX	0/6	
277:NO_DISEASE	MMI	5.18	No Evidence of Coronary Artery Disease	C3275117	[fndg]	["NO DISEASE"-tx-1-"NO DISEASE"-noun-0]	TX	0/10	
278:NO_DISEASE	MMI	5.18	No disease	C0497153	[fndg]	["No disease"-tx-1-"NO DISEASE"-noun-0]	TX	0/10	
282:OSTEOSARCOMA	MMI	20.95	Osteosarcoma	C0029463	[neop]	["OSTEOSARCOMA"-tx-1-"OSTEOSARCOMA"-noun-0]	TX	0/12	C04.557.450.565.575.650;C04.557.450.795.620
283:OSTEOSARCOMA	MMI	5.18	Osteosarcoma of bone	C0585442	[neop]	["osteosarcoma"-tx-1-"OSTEOSARCOMA"-noun-0]	TX	0/12	
285:OVARIAN_CANCER	MMI	5.18	Malignant neoplasm of ovary	C1140680	[neop]	["OVARIAN CANCER"-tx-1-"OVARIAN CANCER"-noun-0]	TX	0/14	
285:OVARIAN_CANCER	MMI	5.18	Malignant neoplasm of ovary	C1140680	[neop]	["OVARIAN CANCER"-tx-1-"OVARIAN CANCER"-noun-0]	TX	0/14	
286:OVARIAN_CANCER	MMI	5.18	Ovarian Carcinoma	C0029925	[neop]	["ovarian cancer"-tx-1-"OVARIAN CANCER"-noun-0]	TX	0/14	
286:OVARIAN_CANCER	MMI	5.18	Ovarian Carcinoma	C0029925	[neop]	["ovarian cancer"-tx-1-"OVARIAN CANCER"-noun-0]	TX	0/14	
287:OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	13.27	Epithelial ovarian cancer	C0677886	[neop]	["ovarian epithelial carcinoma"-tx-1-"OVARIAN EPITHELIAL CARCINOMA"-noun-0]	TX	0/18,26/9	x.x.x.x
288:OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.81	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Ovarian Serous Carcinoma"-tx-1-"OVARIAN SEROUS CARCINOMA"-noun-0]	TX	0/7,19/16	
290:PANCREAS_CANCER	MMI	14.64	Pancreatic carcinoma	C0235974	[neop]	["Pancreas Cancer"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	x.x.x.x
290:PANCREAS_CANCER	MMI	14.64	Pancreatic carcinoma	C0235974	[neop]	["Pancreas Cancer"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	x.x.x.x
291:PANCREAS_CANCER	MMI	5.18	Malignant neoplasm of pancreas	C0346647	[neop]	["Cancer, Pancreas"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	
291:PANCREAS_CANCER	MMI	5.18	Malignant neoplasm of pancreas	C0346647	[neop]	["Cancer, Pancreas"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	
293:PANCREATIC_CANCER	MMI	14.64	Pancreatic carcinoma	C0235974	[neop]	["PANCREATIC CANCER"-tx-1-"PANCREATIC CANCER"-noun-0]	TX	0/17	x.x.x.x
293:PANCREATIC_CANCER	MMI	14.64	Pancreatic carcinoma	C0235974	[neop]	["PANCREATIC CANCER"-tx-1-"PANCREATIC CANCER"-noun-0]	TX	0/17	x.x.x.x
294:PANCREATIC_CANCER	MMI	5.18	Malignant neoplasm of pancreas	C0346647	[neop]	["Pancreatic Cancer"-tx-1-"PANCREATIC CANCER"-noun-0]	TX	0/17	
294:PANCREATIC_CANCER	MMI	5.18	Malignant neoplasm of pancreas	C0346647	[neop]	["Pancreatic Cancer"-tx-1-"PANCREATIC CANCER"-noun-0]	TX	0/17	
297:PARATYPHI_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	10/9	C01.539.221
298:PARATYPHI_INFECTION	MMI	6.83	Infection	C3714514	[patf]	["INFECTION"-tx-1-"INFECTION"-noun-0]	TX	10/9	C01.539
300:PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	12.93	Chromosome Aberrations	C0008625	[comd]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C23.550.210;G05.365.590.175
301:PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.79	Pancytopenia	C0030312	[dsyn]	["Bone Marrow Failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	C15.378.700
302:PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.77	Congenital chromosomal disease	C0008626	[cgab,dsyn]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C16.131.260;C16.320.180
303:PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	3.48	Bone marrow hypocellularity	C1855710	[fndg]	["Bone marrow failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	
304:PDX_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	C04.588.180;C17.800.090.500
304:PDX_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	C04.588.180;C17.800.090.500
304:PDX_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	C04.588.180;C17.800.090.500
305:PDX_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	
305:PDX_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	
305:PDX_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	
306:PDX_BREAST_CANCER	MMI	3.48	Patient Derived Xenograft	C4050317	[emod]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	
306:PDX_BREAST_CANCER	MMI	3.48	Patient Derived Xenograft	C4050317	[emod]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	
306:PDX_BREAST_CANCER	MMI	3.48	Patient Derived Xenograft	C4050317	[emod]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	
310:POLYCYSTIC_KIDNEY	MMI	20.95	Polycystic Kidney Diseases	C0022680	[dsyn]	["KIDNEY, POLYCYSTIC"-tx-1-"POLYCYSTIC KIDNEY"-noun-0]	TX	0/17	C12.777.419.403.875;C13.351.968.419.403.875
311:POLYCYSTIC_KIDNEY	MMI	5.18	Polycystic Kidney - body part	C1567435	[anab]	["Polycystic Kidney"-tx-1-"POLYCYSTIC KIDNEY"-noun-0]	TX	0/17	
315:PROSTATE_CANCER	MMI	5.18	Malignant neoplasm of prostate	C0376358	[neop]	["Prostate Cancer"-tx-1-"PROSTATE CANCER"-noun-0]	TX	0/15	
315:PROSTATE_CANCER	MMI	5.18	Malignant neoplasm of prostate	C0376358	[neop]	["Prostate Cancer"-tx-1-"PROSTATE CANCER"-noun-0]	TX	0/15	
316:PROSTATE_CANCER	MMI	5.18	Prostate carcinoma	C0600139	[neop]	["Prostate Cancer"-tx-1-"PROSTATE CANCER"-noun-0]	TX	0/15	
316:PROSTATE_CANCER	MMI	5.18	Prostate carcinoma	C0600139	[neop]	["Prostate Cancer"-tx-1-"PROSTATE CANCER"-noun-0]	TX	0/15	
317:PULMONARY_HYPERTENSION	MMI	11.49	Pulmonary Hypertension	C0020542	[patf]	["Hypertension, pulmonary"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	C08.381.423
318:PULMONARY_HYPERTENSION	MMI	5.18	Pulmonary Hypertension Adverse Event	C1963220	[fndg]	["Pulmonary hypertension"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	
326:SBH	MMI	24.11	Subcortical Band Heterotopia	C1848201	[dsyn]	["SBH"-tx-1-"SBH"-noun-0]	TX	0/3	C10.500.507.450.230;C10.500.507.450.499.230;C16.131.666.507.450.230;C16.131.666.507.450.499.230;C16.320.322.500.186
327:SBH	MMI	14.64	SUBCORTICAL BAND HETEROTOPIA, X-LINKED	C1848200	[dsyn]	["SBH"-tx-1-"SBH"-noun-0]	TX	0/3	x.x.x.x
337:SMALL_CELL_LUNG_CANCER	MMI	27.26	Small cell carcinoma of lung	C0149925	[neop]	["Lung cancer, small cell"-tx-1-"SMALL CELL LUNG CANCER"-noun-0]	TX	0/22	C04.588.894.797.520.109.220.624;C08.381.540.140.750;C08.785.520.100.220.750
337:SMALL_CELL_LUNG_CANCER	MMI	27.26	Small cell carcinoma of lung	C0149925	[neop]	["Lung cancer, small cell"-tx-1-"SMALL CELL LUNG CANCER"-noun-0]	TX	0/22	C04.588.894.797.520.109.220.624;C08.381.540.140.750;C08.785.520.100.220.750
341:STARGARDT_DISEASE;_EARLY-ONSET	MMI	13.14	Stargardt's disease	C0271093	[fndg]	["STARGARDT DISEASE"-tx-1-"STARGARDT DISEASE"-noun-0]	TX	0/17	x.x.x.x
342:STARGARDT_DISEASE;_EARLY-ONSET	MMI	3.50	Early-onset	C1833334	[fndg]	["Early-onset"-tx-1-"EARLY-ONSET"-adj-0]	TX	19/11	
344:STEROID-RESISTANT_NEPHROTIC_SYNDROME	MMI	5.18	Steroid resistant nephrotic syndrome of childhood	C3266102	[dsyn]	["Steroid-Resistant Nephrotic Syndrome"-tx-1-"STEROID-RESISTANT NEPHROTIC SYNDROME"-noun-0]	TX	0/36	
345:STEROID-RESISTANT_NEPHROTIC_SYNDROME	MMI	5.18	Steroid-resistant nephrotic syndrome	C0403397	[dsyn]	["Nephrotic syndrome, steroid-resistant"-tx-1-"STEROID-RESISTANT NEPHROTIC SYNDROME"-noun-0]	TX	0/36	
349:TERMINAL_HEART_FAILURE	MMI	10.06	Heart failure	C0018801	[dsyn]	["Failure, Heart"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	C14.280.434
350:TERMINAL_HEART_FAILURE	MMI	3.75	Congestive heart failure	C0018802	[dsyn]	["Heart Failure"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	
351:THERAPY-RELATED_AML	MMI	16.25	Leukemia, Myelocytic, Acute	C0023467	[neop]	["AML"-tx-1-"AML"-noun-0]	TX	16/3	C04.557.337.539.275
352:THERAPY-RELATED_AML	MMI	3.48	Related personal status	C0445223	[fndg]	["Related"-tx-1-"RELATED"-adj-0]	TX	8/7	
353:THERAPY-RELATED_AML	MMI	3.48	Therapy Object (animal model)	C1363945	[fndg]	["Therapy"-tx-1-"THERAPY"-noun-0]	TX	0/7	
354:THYROID_CANCER	MMI	5.18	Malignant neoplasm of thyroid	C0007115	[neop]	["-- Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
354:THYROID_CANCER	MMI	5.18	Malignant neoplasm of thyroid	C0007115	[neop]	["-- Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
355:THYROID_CANCER	MMI	5.18	Thyroid carcinoma	C0549473	[neop]	["Cancer, Thyroid"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
355:THYROID_CANCER	MMI	5.18	Thyroid carcinoma	C0549473	[neop]	["Cancer, Thyroid"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
357:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	17.80	Triple Negative Breast Neoplasms	C3539878	[neop]	["Triple-Negative Breast Cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	C04.588.180.788;C17.800.090.500.788
357:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	17.80	Triple Negative Breast Neoplasms	C3539878	[neop]	["Triple-Negative Breast Cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	C04.588.180.788;C17.800.090.500.788
357:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	17.80	Triple Negative Breast Neoplasms	C3539878	[neop]	["Triple-Negative Breast Cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	C04.588.180.788;C17.800.090.500.788
358:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	5.18	Triple-Negative Breast Cancer Finding	C2348819	[fndg]	["triple-negative breast cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	
358:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	5.18	Triple-Negative Breast Cancer Finding	C2348819	[fndg]	["triple-negative breast cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	
358:TRIPLE-NEGATIVE_BREAST_CANCER	MMI	5.18	Triple-Negative Breast Cancer Finding	C2348819	[fndg]	["triple-negative breast cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	
372:WELL-DIFFERENTIATED_LIPOSARCOMA	MMI	17.80	Atypical Lipoma	C1266129	[neop]	["Well Differentiated Liposarcoma"-tx-1-"WELL-DIFFERENTIATED LIPOSARCOMA"-noun-0]	TX	0/31	C04.557.450.550.400
373:WELL-DIFFERENTIATED_LIPOSARCOMA	MMI	5.18	Liposarcoma, well differentiated	C1370889	[neop]	["Liposarcoma, well differentiated"-tx-1-"WELL-DIFFERENTIATED LIPOSARCOMA"-noun-0]	TX	0/31	
